Lab business

Science talk at Sydney's Royal Botanic Garden

29 November, 2013

The Royal Botanic Gardens and Domain Trust is hosting a talk on plant conservation at the Royal Botanic Garden Sydney on 9 December.


Morrison & Foerster releases BioMeter index for Q3

27 November, 2013

Law firm Morrison & Foerster (MoFo) has released its latest BioMeter index, a quarterly deal report which measures the health of the biotechnology industry by tracking up-front licensing payments for pharma and biotech assets.


Biological scientist named WA's Tall Poppy for 2013

27 November, 2013

Professor Ryan Lister, a genome biologist and Future Fellow in the ARC Centre for Excellence in Plant Energy Biology, has won the 2013 Tall Poppy Awards for Western Australia.


Research scholarships to help the sugarcane industry

26 November, 2013

Sugar Research Australia (SRA) is calling for applications for research funding and postgraduate scholarships that will help build the profitability, productivity and sustainability of the Australian sugarcane industry.


Merck Biopharm osteoarthritis co-research agreement

22 November, 2013

Biopharm and Merck Serono have entered a joint discovery project focusing on a potential pro-anabolic osteoarthritis modifying drug based on a growth factor derived from the Biopharm growth factor platform technology.


Nancy Millis Medal to honour women in science

22 November, 2013

The Australian Academy of Science has created a new award - the Nancy Millis Medal - which recognises outstanding research and leadership by early- to mid-career Australian women who have established independent research in the natural sciences.


Questacon celebrates 25th anniversary

22 November, 2013

Saturday 23 November marks the 25th anniversary of Questacon - The National Science and Technology Centre. The multiaward-winning tourist attraction features eight galleries with over 200 interactive exhibits.


Crowd funding to fight melioidosis

20 November, 2013

Researchers from James Cook University (JCU), who recently developed a highly sensitive and rapid multiplex diagnostic test for melioidosis, have launched a crowd funding campaign to help make their test a reality.


Director of Australian Synchrotron announced

20 November, 2013

The Synchrotron Light Source Australia (SLSA) Board today announced the appointment of Professor Andrew Peele as Director of the Australian Synchrotron. Professor Peele has held the role on an interim basis since the beginning of 2013, overseeing the day-to-day delivery of world-class science at the facility.


NMI Prize for 2013 awarded

20 November, 2013

Physicist Dr Daniel Creedon was yesterday awarded the prestigious federal government National Measurement Institute (NMI) Prize at a ceremony in Sydney, where he gave a seminar on his award-winning work. Dr Creedon was announced as the winner of the prize on World Metrology Day earlier this year.


NZ Prime Minister's Science Prizes awarded

15 November, 2013

The 2013 Prime Minister's Science Prizes were this week awarded at the Royal Society of New Zealand in Wellington. With a total of $1 million in prize money, the awards aim to highlight the contribution science makes to New Zealand's economy.


SCU research funded by ARC

15 November, 2013

Southern Cross University (SCU) has received $1.21 million in funding from the Australian Research Council (ARC). This follows Minister for Education Christopher Pyne's announcement that the council will provide $522 million to fund 1177 research projects around Australia.


Workshop explores the challenge of taking stem cell therapy to market

11 November, 2013

The NSW Stem Cell Network is hosting a workshop to address the future of stem cell research in Australia and the gap in taking innovative stem cell therapies to patients.


Strategic agreement to help fix the body's leaky pipes

07 November, 2013

Danish biotechnology company Mirrx Therapeutics and Sydney's Centenary Institute of Cancer Medicine and Cell Biology have executed a strategic collaboration and commercialisation agreement to discover and develop therapeutic oligonucleotide drug candidates targeting vascular endothelial cadherin (VE-cadherin).


Janssen Industry Excellence Awards presented at AusBiotech 2013

01 November, 2013

The Janssen Industry Excellence Awards, held this week during the AusBiotech 2013 national conference in Brisbane, every year recognise outstanding commercialisation of innovative healthcare solutions by Australian biotechnology and healthcare companies. The 2013 Company of the Year award was presented to Nanosonics.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd